Impact of skeletal complications on patients' quality of life, mobility, and functional independence.
AffiliationInstituto de Medicina Molecular-Lisboa, Servico de Oncologia, Hospital de Santa Maria, Av Professor Egaz Moniz, Lisbon, 1649-039, Portugal. email@example.com
MetadataShow full item record
AbstractINTRODUCTION: Skeletal-related events (SREs) from malignant bone disease cause considerable morbidity and can dramatically reduce patients' quality of life. DISCUSSION: Pathologic fractures often require surgical intervention and palliative radiotherapy. Thus, patients suffer impaired mobility, loss of functional independence, and diminished health-related quality of life (HRQOL). Bisphosphonates can delay the onset and reduce the incidence of SREs and have become the standard of care for the treatment of malignant bone disease; however, minimal information on the effects of bisphosphonate treatment on HRQOL is available. Targeted HRQOL assessments for patients with malignant bone disease are currently under development and are discussed herein.
CitationImpact of skeletal complications on patients' quality of life, mobility, and functional independence. 2008, 16 (8):879-89 Support Care Cancer
JournalSupportive Care in Cancer
- Bisphosphonates: reducing the risk of skeletal complications from bone metastasis.
- Authors: Costa L
- Issue date: 2007 Dec
- Prognostic factors for skeletal complications from metastatic bone disease in breast cancer.
- Authors: Brown JE, Cook RJ, Lipton A, Costa L, Coleman RE
- Issue date: 2010 Oct
- Optimal management of metastatic bone disease.
- Authors: Major P
- Issue date: 2007
- Relationship between incidence of fracture and health-related quality-of-life in metastatic breast cancer patients with bone metastases.
- Authors: Walker MS, Miller PJ, Namjoshi M, Houts AC, Stepanski EJ, Schwartzberg LS
- Issue date: 2013